|
2025
|
G/S
|
Pharmaceuticals. |
|
|
G/S
|
Providing medical information Providing medical information Providing medical information Providi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central ner... |
|
|
Invention
|
Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agents.
Anti-cancer combin... |
|
|
G/S
|
Pharmaceutical preparations for prevention or treatment of infectious diseases Pharmaceutical pre... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of infectious diseases Pharmaceutica... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, canc... |
|
|
Invention
|
Pyridinone derivatives as selective cytotoxic agents against hiv infected cells.
The present dis... |
|
|
Invention
|
System for medicinal supply monitoring and management with controlled packaging of medicinal prod... |
|
|
Invention
|
System for medicinal supply monitoring and management for pooled medicinal product across studies... |
|
|
Invention
|
System for medicinal supply monitoring and management with digital display labeling.
A medicinal... |
|
|
Invention
|
System for medicinal supply monitoring and management. A medicinal supply management system manag... |
|
|
Invention
|
N-oxide derivatives as selective cytotoxic agents. The present disclosure is directed to N-oxide ... |
|
|
Invention
|
Modulation of cell growth and viability using nucleoside transport inhibitors, inhibitors of aden... |
|
|
Invention
|
Combination therapies for the treatment of hr+/her2- metastatic or locally advanced breast cancer... |
|
|
Invention
|
3-sulfamoyl benzoate ester and benzamide compounds as tead modulators. Provided are compounds of ... |
|
|
Invention
|
Methods and compositions for treatment of cancer with anti-cd27 antibodies. The present disclosur... |
|
|
Invention
|
N-biaryl sulfonamides as modulators of the hippo pathway. Provided are compounds of Formula I: an... |
|
|
Invention
|
Evaluating neural network prediction confidence using generative reconstruction of test image.
A... |
|
|
Invention
|
Treatment of migraine.
The present disclosure provides methods for the acute treatment of migrai... |
|
|
Invention
|
Methods of using cyclic peptides that bind to tnfr1. Provided herein, in certain aspects, are met... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
|
Invention
|
Methods of separating host cell lipases from a production protein in chromatographic processes.
... |
|
|
Invention
|
Viral fusion inhibitors. The present invention relates to viral fusion inhibitors, as well as use... |
|
2024
|
G/S
|
pharmaceutical preparations for veterinary use, namely, anti-inflammatories, insecticides, and ho... |
|
|
Invention
|
Agonists of trem2 activity. The present disclosure is directed to compounds of Formula (I) and th... |
|
|
Invention
|
Agonists of trem2 activity. The present disclosure is directed to compounds of Formula I and thei... |
|
|
Invention
|
Pcsk9 antagonist compounds.
Disclosed are compounds of Formula I, or a salt thereof:
Disclosed... |
|
|
Invention
|
Substituted isoquinoline derivatives and methods of use thereof. Provided are novel Substituted I... |
|
|
Invention
|
Process for preparing n-aminoalkylated tryptophan compounds. The present invention relates to pro... |
|
|
Invention
|
Methods of treating a patient with a pd-1 antagonist. The invention relates to a method of treati... |
|
|
Invention
|
Process for preparing (s)-1-((s)-2-amino-3-(4-methoxyphenyl)propanoyl)-n-(4-(hydroxymethyl)phenet... |
|
|
Invention
|
Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3.
Novel compounds of ... |
|
|
Invention
|
Indazole derivatives useful as inhibitors of nod-like receptor protein 3.
Novel compounds of For... |
|
|
Invention
|
Indazole derivatives useful as inhibitors of nod-like receptor protein 3. Novel compounds of Form... |
|
|
Invention
|
Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3. Novel compounds of F... |
|
|
Invention
|
A cyclic peptide il-1beta trap for the treatment of atherosclerosis and inflammatory disorders. P... |
|
|
G/S
|
Pharmaceutical preparations for use in Oncology |
|
|
Invention
|
Combination therapy of a pd-1 antagonist and lag3 antagonist and all-trans retinoic acid or a pha... |
|
|
Invention
|
Methods of purifying anti-pd-1 antibodies or antigen-binding fragments thereof using mixed-mode a... |
|
|
Invention
|
Methods for treating pulmonary arterial hypertension with activin receptor type iia (actriia) pro... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
Invention
|
Fluid path tube. In some examples, a tubing assembly for an injection device includes a tubing ha... |
|
|
Invention
|
Fluid flow path for injector. In some examples, a tubing assembly for an injection device include... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals; human vaccine preparations p... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
Pharmaceuticals and vaccines for human and veterinary use;
medicinal, pharmaceutical, therapeuti... |
|
|
Invention
|
26-valent pneumococcal conjugate vaccines and methods of use thereof. S. pneumoniae S. pneumoniae... |
|
|
Invention
|
Pneumococcal conjugate vaccines and methods of use thereof.
The invention is related to 26-valen... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
|
Invention
|
Interactive gowning and gowning verification.
A device includes a camera, a display and a comput... |
|
2023
|
G/S
|
Providing medical information relating to cancer Personal support services for cancer patients, n... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
|
Invention
|
Engineered enzyme for preparing a hydroxylated indanone intermediate useful in the synthesis of b... |
|
|
Invention
|
Orexin receptor agonists.
The present invention is directed to compounds of Formula I which are ... |
|
|
Invention
|
Stable formulations of anti-ilt4 antibodies or antigen-binding fragments thererof in combination ... |
|
|
Invention
|
Process for preparing agglomerated crystalline medium-chain fatty acid sodium salts.
The process... |
|
|
Invention
|
Process for preparing ((1s,2s)-2-(5-methylpyridin-2-yl)cyclopropyl)-methanol.
The present invent... |
|
|
Invention
|
Process for preparing ((1s,2s)-2-(5-methylpyridin-2-yl)cyclopropyl)methanol.
Described is an eff... |
|
|
Invention
|
Controlled release vaccine formulations.
The present disclosure provides, among other things, a ... |
|
|
Invention
|
Non-aromatic cyclic-pyrimidine analogs as glucosylceramide synthase inhibitors.
The present inve... |
|
|
Invention
|
Protease inhibitors for treating or preventing coronavirus infection.
The present invention prov... |
|
2022
|
Invention
|
Multi-cartridge injector and methods of making and using same.
A multi-cartridge injector includ... |
|
|
Invention
|
Treatment of viruses with antiviral nucleosides.
Therapies comprising administering at least one... |
|
|
Invention
|
Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof.
Disclosed herein are ... |
